The Safety of Allergen Immunotherapy: A Literature Review

Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1:572.

Freeman J. Further observations on the treatment of hayfever by hypodermic inoculation of pollen vaccine. Lancet 1911;2:814.

Curtis HH . The immunizing cure for hay fever. Med News 1900;77:16.

Lamson RW . So-called fatal anaphylaxis in man. JAMA 1929;93:1975–78.

Lockey RF , Benedict LM , Turkeltaub PC , Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987;79(4)660–7.

Norman PS , VanMetre TE . The safety of allergenic immunotherapy. J Allergy Clin Immunol 1990;85(2):522–5.

Davis WE , Cook PR , McKinsey JP , Anaphylaxis in immunotherapy. Otolaryngol Head Neck Surg 1992;107:78–83.

Reid MJ , Lockey RF , Turkeltaub PC , Survey of fatalities from skin testing and immunotherapy 1985–1989. J Allergy Clin Immunol 1993;92(Pt. 1):6–15.

Van Arsdel PP , Sherman WB . The risk of inducing constitutional reactions in allergic patients. J Allergy 1957;28(3):251–61.

Greenburg MA , Kaufman CR , Gonzalez GE , Late and immediate systemic-allergic reaction to inhalant allergen immunotherapy. J Allergy Clin Immunol 1986;77(6):865–70.

Cooke RA . Studies in specific hypersensitivity III: The dangers of the diagnostic cutaneous test and therapeutic injection of allergens. J Immunol 1922;7(119):119–46.

Vervloet D , Khairallah E , Arnaud A , Prospective national study of the safety of immunotherapy. Clin Allergy 1980;10:59.

Ranson JH . Frequency of reactions to alum-precipitated ragweed extract. Ann Allergy 1971;29:635.

Kaufman CR , Summers RJ , Renard RL . Safety of immunotherapy: A prospective study. Ann Allergy 1984;52:220–6

Levine MI . Systemic reactions to immunotherapy. J Allergy Clin Immunol 1979;63:209.

Figley KD . The continuous method of hayfever treatment. J Allergy 1931;2:39.

Furstonberg FF , Gay LN . The occurrence of constitutional reactions in the treatment of hayfever and asthma: Analysis of corrective factors. Bull Johns Hopkins 1937;60:412.

Iliopoulos O , Proud D , Adkinson NF Jr. , Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: Changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87(4):855–66.

Furin MJ , Norman PS , Creticos PS , Immunotherapy decreases antigen induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunology 1991;88(1):364–72.

Lin MS , Tanner E , Lynn J , Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 1993;71:557–62.

Tinkelman DG , Cole WQ , Tunno J. Immunotherapy: A one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 1995;95(1: Pt 1):8–14.

Cook PR , Bryant JL , Davis WE , Systemic reactions to immunotherapy: The AAOA Morbidity and Mortality Survey. Otolaryngol Head Neck Surg 1994;110(6):487–93.

Gordon BR . Allergy skin test and immunotherapy: Comparisons of methods in common use. Ear Nose Throat J 1990;69:47–61.

Willoughby JW . New concepts in immunotherapy. Otolaryngol Clin North Am 1992;25(1):71–100.

Ward WA . Immunotherapy dosage based on skin endpoint titration. In: Mabry RL (ed). Skin endpoint titration (AAOA monograph series). New York: Thieme Medical Publications, 1992:39–42.

King HC . Endpoint titration and immunotherapy. Otolaryngol Clin North Am 1985;18:703–17.

Greineder DK . Risk management in allergen immunotherapy. J Allergy Clin Immunol 1996;98:S330–4.

Kay AB . Allergen injection immunotherapy (hypersensitization on trial). Clin Exper Allergy 1989;19:591–6.

Gordon BR . Immunotherapy: Rationale and mechanisms. Otolaryngol Head Neck Surg 1992:107(6: Pt. 2):861–5.